Skip to main content
. 2021 Jul 28;9(7):e27343. doi: 10.2196/27343

Table 2.

Consensus statements on ethics of mental health applications of digital phenotyping.

Statementa Agreement levelb

Necessity Feasibility
Evidence of validity for the intended use

Algorithms incorporated into a digital phenotyping tool, especially at a large scale, have to be thoroughly evaluated in terms of performance and accuracy, including false positives and false negatives. Strong Strong

Implement processes for review of digital phenotyping tools’ effectiveness after implementation, including review of updates, and monitoring and reporting of adverse events caused by an algorithm’s findings. Strong Moderate

Digital phenotyping tools that are intended for use in health care should use relevant standards for data systems to support the goal of interoperability with existing health data systems. Strong Moderate

Digital phenotyping tools for mental health applications should respond to real-world needs and concerns of the intended users, such as clinicians, patients or consumers, in order to enhance user engagement and provide value. Strong Strong
Transparency

Explanations of the processes, risks, limitations, and results that are relevant to different stakeholders should be provided to them in an appropriate format and reading level. Strong Strong

Processes involved in the collection, storage, and dissemination of raw data, as well as data processing and the architecture of the algorithms, should be explainable. Strong Moderate
Accountability

Development and use of digital phenotyping tools (eg, plans for data collection or validation) should be reviewed for potential ethical issues by an independent interdisciplinary group with relevant expertise, starting early in the development process. Strong Moderate

Provision of appropriate educational and training materials for IRBsc handling review of digital phenotyping projects is also necessary. Strong Moderate
Consent

Consent should be required from individuals when their personal data are collected for digital phenotyping tools. Strong Moderate

Consent for collection of digital phenotyping data should include information at a sixth-grade level regarding the types of data collected, the inferences that can be drawn from the data, the reports made from the data, who the data and reports would be shared with, the potential risks and benefits to the user, and the limitations that apply to the findings. Strong Moderate

Include relevant stakeholders in efforts to formulate and disseminate relevant information for disclosure (eg, data storage, utilizing appropriate languages and formats for relevant stakeholders, such as health care providers, government institutions, advocacy organizations, patients, consumers, or the public). Strong Strong
Data security and privacy

Data and findings that are identifying should not be collected, used or shared with third parties without the informed consent of that individual. Strong Strong

Sharing of data to advance scientific research and the validity of the tools remains an important goal. Strong Moderate

If data will be shared with third-party researchers, clear information, written at sixth-grade reading level, must be given to the individual user about third-party researcher and how they plan to store, use and/or share the data. Strong Strong

The individual user also must have an option to opt out of sharing their data with third parties. Strong Moderate

Raw data that is nonidentifying, and nonidentifying summary statistics, may be shared without consent. Strong Strong

There should be periodic review to re-evaluate whether identifying information can be drawn from the raw data, particularly when combined with other available data. Moderate Moderate

Raw data should always be encrypted when stored or transmitted; potential identifiers in data (eg, phone numbers and IP addresses) should be replaced with surrogates (eg, hashed or encrypted). Moderate Moderate

Standards and approaches to minimize risk of reidentification of individuals, such as differential privacy measures, should be implemented. Strong Moderate

The security standards for data storage, sharing, and use of the individual’s data, as well as the process for monitoring compliance with these standards, should be clearly defined and communicated to users of digital phenotyping tools. Strong Moderate

Security reviews and audits of data practices should also be implemented. Strong Moderate
Fairness

Encourage collaborative research and partnerships to develop ways to identify and minimize bias or discrimination in the development of digital phenotyping tools and to identify and minimize any potential bias that may occur because of how the tools may be used in different communities or local contexts. Moderate Moderate

Conduct research into and implement methods to mitigate bias in different levels of algorithm development, including in the training data, in the algorithmic process or focus, in the transfer of digital phenotyping tools to different contexts, and in the interpretation of digital phenotyping findings. Strong Strong

Identify the specific ways that mental health and clinical care may impact the potential for bias in these areas. Periodic review and re-evaluation of the methods for addressing and mitigating bias at the different levels of algorithmic development may be needed. Strong Strong

aThe statements represent the ethical issues in digital phenotyping for mental health applications resulting from the interviews and the first survey.

bThe agreement rating listed represents the level of consensus for statements that were determined through the second survey.

cIRB: institutional review board.